Studies on the pathologic physiology of pulmonary hypertension in mitral valvular disease. 1. The role of sympathetic nervous system on the increment of pulmonary vascular resistance.
D000293:Adolescent; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002395:Catecholamines / Q000652:urine; D004837:Epinephrine / Q000652:urine; D005260:Female; D006330:Heart Defects, Congenital / Q000150:complications; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology* / Q000503:physiopathology / Q000652:urine; D008297:Male; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000150:complications*; D009638:Norepinephrine / Q000652:urine; D010100:Oxygen / Q000097:blood / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011652:Pulmonary Circulation; D013564:Sympathetic Nervous System / Q000502:physiology*; D014655:Vascular Resistance
D002395:Catecholamines; D006584:Hexamethonium Compounds; D010100:Oxygen; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine